Articles with public access mandates - Jonathan FinlayLearn more
Not available anywhere: 4
Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis
S Rutkowski, K Von Hoff, A Emser, I Zwiener, T Pietsch, ...
Journal of clinical oncology 28 (33), 4961-4968, 2010
Mandates: Cancer Research UK
Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A 5971 trial: a report from the C hildren's O ncology G roup
AM Termuhlen, LM Smith, SL Perkins, M Lones, JL Finlay, H Weinstein, ...
British journal of haematology 162 (6), 792-801, 2013
Mandates: US National Institutes of Health
Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015
H Gittleman, G Cioffi, T Vecchione-Koval, QT Ostrom, C Kruchko, ...
Journal of Neuro-oncology 143, 251-260, 2019
Mandates: US National Institutes of Health, Cancer Prevention Research Institute of …
Pediatric Gliosarcoma with and without Neurofibromatosis type 1: a whole-exome comparison of 2 patients
RT Graham, EH Bell, A Webb, Y Zhao, C Timmers, JL Fleming, BE Sells, ...
Journal of Pediatric Hematology/Oncology 43 (8), e1201-e1204, 2021
Mandates: US National Institutes of Health
Available somewhere: 66
CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012
QT Ostrom, H Gittleman, J Fulop, M Liu, R Blanda, C Kromer, Y Wolinsky, ...
Neuro-oncology 17 (suppl_4), iv1-iv62, 2015
Mandates: US National Institutes of Health
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study
A Villani, A Shore, JD Wasserman, D Stephens, RH Kim, H Druker, ...
The Lancet Oncology 17 (9), 1295-1305, 2016
Mandates: Canadian Cancer Society, Canadian Institutes of Health Research
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study
A Villani, U Tabori, J Schiffman, A Shlien, J Beyene, H Druker, ...
The lancet oncology 12 (6), 559-567, 2011
Mandates: Canadian Institutes of Health Research
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants
KW Pajtler, SC Mack, V Ramaswamy, CA Smith, H Witt, A Smith, ...
Acta neuropathologica 133, 5-12, 2017
Mandates: US National Institutes of Health, Cancer Research UK
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
AS Guerreiro Stucklin, S Ryall, K Fukuoka, M Zapotocky, A Lassaletta, ...
Nature Communications 10 (1), 4343, 2019
Mandates: Canadian Cancer Society, Canadian Institutes of Health Research, Genome …
American brain tumor association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008-2012
QT Ostrom, H Gittleman, PM De Blank, JL Finlay, JG Gurney, ...
Neuro-oncology 18 (suppl_1), i1-i50, 2016
Mandates: US National Institutes of Health
TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors
U Tabori, A Shlien, B Baskin, S Levitt, P Ray, N Alon, C Hawkins, ...
Journal of clinical oncology 28 (12), 1995-2001, 2010
Mandates: Canadian Institutes of Health Research
Pilot study of intensive chemotherapy with peripheral hematopoietic cell support for children less than 3 years of age with malignant brain tumors, the CCG-99703 phase I/II …
BH Cohen, JR Geyer, DC Miller, JG Curran, T Zhou, E Holmes, SA Ingles, ...
Pediatric neurology 53 (1), 31-46, 2015
Mandates: US National Institutes of Health
Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941
EJ Lowe, R Sposto, SL Perkins, TG Gross, J Finlay, D Zwick, ...
Pediatric blood & cancer 52 (3), 335-339, 2009
Mandates: US National Institutes of Health
Clinical, pathological, and molecular characterization of infant medulloblastomas treated with sequential high‐dose chemotherapy
L Lafay‐Cousin, A Smith, SN Chi, E Wells, J Madden, A Margol, ...
Pediatric blood & cancer 63 (9), 1527-1534, 2016
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Tumor-associated macrophages in SHH subgroup of medulloblastomas
AS Margol, NJ Robison, J Gnanachandran, LT Hung, RJ Kennedy, M Vali, ...
Clinical Cancer Research 21 (6), 1457-1465, 2015
Mandates: US National Institutes of Health
Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition
L Nobre, M Zapotocky, V Ramaswamy, S Ryall, J Bennett, D Alderete, ...
JCO precision oncology 4, 561-571, 2020
Mandates: US National Institutes of Health, Canadian Cancer Society, Canadian …
Phase II study of pre‐irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology Group
JH Garvin Jr, MT Selch, E Holmes, MS Berger, JL Finlay, A Flannery, ...
Pediatric blood & cancer 59 (7), 1183-1189, 2012
Mandates: US National Institutes of Health
EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults
D Frappaz, G Dhall, MJ Murray, S Goldman, C Faure Conter, J Allen, ...
Neuro-oncology 24 (4), 516-527, 2022
Mandates: US National Institutes of Health
Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy
S Blüml, AS Margol, R Sposto, RJ Kennedy, NJ Robison, M Vali, LT Hung, ...
Neuro-oncology 18 (1), 126-131, 2015
Mandates: US National Institutes of Health
Outcome of infants and young children with newly diagnosed ependymoma treated on the “Head Start” III prospective clinical trial
R Venkatramani, L Ji, J Lasky, K Haley, A Judkins, S Zhou, R Sposto, ...
Journal of neuro-oncology 113, 285-291, 2013
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program